Skip to main content

Table 2 Sensitivity analysis of the prevalence of dual contraceptive utilization among HIV positive women in Ethiopia 2020

From: Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020

Study omitted Prevalence (%) 95%CI
Abay et al. (2020) [13] 25.99 20.82–31.16
Reta et al. (2019) [14] 26.86 21.79–31.95
Kebede et al. (2015) [15] 26.11 20.92–31.30
Egzeabher et al. (2015) [16] 26.54 21.34–31.74
Tewabe et al. (2018) 26.15 20.95–31.35
Asfaw et al. (2014) [17] 26.59 21.40–31.78
Demissie et al. (2015) [18] 25.81 20.69–30.93
Sufa et al. (2013) [19] 26.35 21.13–31.56
Polis et al. (2014) [20] 26.65 21.47–31.82
Dereje (2019) [21] 24.28 20.37–28.18
Feyissa et al. (2020) [22] 26.65 21.47–31.82
Tesfaye et al. (2014) [23] 25.82 20.69–30.94
Gebrehiwot et al. (2017) [24] 26.72 21.57–31.87
Kalayu (2019) [25] 25.08 20.31–29.85
Melaku et al. (2014) [26] 26.81 21.72–31.91
Berhane et al. (2013) [27] 26.39 21.17–31.60
Assefa et al. (2014) [28] 25.32 20.40–30.23
Markos et al. (2019) [29] 26.02 20.84–31.19
Meseret et al. (2015) [30] 26.49 21.28–31.70